Biofeedback Devices Global Market Report 2025

The biofeedback devices market size has grown rapidly in recent years. It will grow from $3.34 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be linked to the rising prevalence of stress-related disorders, increased awareness of mental health and wellness, growing use of wearable health technologies, higher demand for non-invasive and drug-free treatment options, and broader applications in rehabilitation and chronic disease management.

The biofeedback devices market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth during the forecast period can be attributed to the greater integration with digital platforms and mobile apps, increased investments in digital therapeutics and neurotechnology, wider availability of home-use and consumer-grade devices, more support from insurance providers for biofeedback therapy, and growing clinical evidence validating the effectiveness of biofeedback. Key trends during the forecast period include advancements in wearable sensor technology, the merging of biofeedback with mobile health platforms, the convergence of technology with artificial intelligence and machine learning, progress in brain-computer interface and neurofeedback systems, and improvements in cloud computing for remote monitoring.

The growing prevalence of stress-related disorders is expected to drive the expansion of the biofeedback devices market in the coming years. These disorders, which encompass mental and physical health issues resulting from prolonged or excessive stress, are becoming more common due to rising work pressures and lifestyle imbalances in modern society. Biofeedback devices are used to help individuals monitor and regulate physiological responses, such as heart rate and brainwaves, promoting relaxation and stress reduction. For example, in May 2024, the American Psychiatric Association reported that the percentage of US adults experiencing heightened anxiety reached 43% in 2024, up from 37% in 2023 and 32% in 2022. As stress-related disorders continue to rise, the demand for biofeedback devices is also increasing.

Key companies in the biofeedback devices market are focusing on innovative technological solutions, such as wearable biofeedback devices, to provide real-time monitoring, improve user experience, and offer personalized data-driven insights for mental health and overall well-being. A wearable biofeedback device is a portable gadget that monitors physiological signals, such as heart rate, skin temperature, or brain activity, providing real-time feedback for stress management and health improvement. For instance, in January 2024, BramhAnsh Technologies, an India-based company, launched SOONYAM, a wearable biofeedback device that uses Galvanic Skin Response (GSR) technology to monitor mental states. The device tracks electrodermal activity to offer real-time insights into psychological arousal, stress levels, and mental effort. Designed for individuals, counselors, and practitioners, it features a user-friendly interface and integrates seamlessly into daily routines such as meditation and sleep monitoring.

In November 2023, Noldus IT, a Netherlands-based company specializing in behavioral research technology, partnered with Bitbrain, a Spain-based provider of advanced biofeedback and neurofeedback devices. This collaboration aims to improve the integration of behavioral and neural data in research by combining Noldus' Observer XT software with Bitbrain's Diadem dry-EEG headset, advancing behavioral neuroscience research.

Major players in the biofeedback devices market are QX World Ltd., Laborie Inc., Zynex Medical Inc., NeuroSky Inc., Thought Technology Ltd., HeartMath LLC, Medicaid Systems Pvt. Ltd., Neurocare Group AG, MediTouch Ltd., Great Lakes NeuroTechnologies Inc., Quantum World Vision Inc., BrainMaster Technologies Inc., Mind Media B.V., ELMIKO Medical Equipment, Mindfield Biosystems Ltd., mTrigger LLC, BEE Medic GmbH, Fisiocomputer S.r.l., Mohans Electronics & Illuminators, InteraXon Inc.

North America was the largest region in the biofeedback devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biofeedback devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biofeedback devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Biofeedback devices are electronic tools designed to monitor physiological signals and provide real-time feedback, allowing users to consciously regulate bodily functions to enhance their health and well-being. These devices capture physiological data and offer feedback to help users control functions such as heart rate, muscle tension, or brain activity for therapeutic or performance-enhancing purposes.

The main types of biofeedback devices measure brainwaves, heart rate, muscle tone, sweat gland activity, temperature, pulmonary functions, and other physiological signals. Brainwaves, which are electrical patterns of brain activity, are measured by these devices to help users monitor and regulate mental states such as relaxation, focus, or stress. The devices use various technologies, including electromyography (EMG), electroencephalography (EEG), and heart rate variability (HRV). They are distributed through online retail, physical retail, and direct sales. These devices are used in various settings such as home use, hospitals, clinics, rehabilitation centers, and research institutions. The key end-users include individuals, healthcare providers, and corporate wellness programs.

The biofeedback devices market research report is one of a series of new reports that provides biofeedback devices market statistics, including the biofeedback devices industry global market size, regional shares, competitors with the biofeedback devices market share, detailed biofeedback devices market segments, market trends, and opportunities, and any further data you may need to thrive in the biofeedback devices industry. This biofeedback devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biofeedback devices market consists of revenues earned by entities providing services such as monitoring, training, and therapy aimed at helping individuals regulate physiological functions such as heart rate, muscle activity, brainwaves, and stress responses. The market value includes the value of related goods sold by the service provider or included within the service offering. The biofeedback devices market also includes sales of equipment such as thermal biofeedback devices, heart rate variability monitors, wearable sensors and rehabilitation therapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.